Hjem › Migrene › District of Columbia
Kliniske studier for Migrene i District of Columbia
5 studier for Migrene søker deltakere på steder i District of Columbia.
Byer i District of Columbia
Offisiell studietekst (engelsk)
A Study to Learn About the Study Medicine Called Zavegepant (PF-07930207) in Children With a History of Migraine
- Velocity Clinical Research, Washington DC, Washington D.C.
RekruttererFase 1
Alder 6 til 11 · Alle kjønn · Oppdatert 28. sep. 2026 · NCT06995729Efficacy and Safety Study of Rimegepant for the Preventative Treatment of Migraine in Pediatric Subjects
- Velocity Clinical Research, Washington DC, Washington D.C.
RekruttererFase 3
Alder 6 til 17 · Alle kjønn · Oppdatert 28. sep. 2026 · NCT05156398Randomized Study in Children and Adolescents With Migraine: Acute Treatment
- Children's National Medical Center, Washington D.C.
RekruttererFase 3
Alder 6 til 17 · Alle kjønn · Oppdatert 24. sep. 2026 · NCT04649242Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine
- Children's National Medical Center, Washington D.C.
RekruttererFase 3
Alder 6 til 17 · Alle kjønn · Oppdatert 24. sep. 2026 · NCT04743141Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)
- Emerson Clinical Research Institute - Connecticut Avenue - Washington /ID# 231693, Washington D.C.
RekruttererFase 3
Alder 6 til 17 · Alle kjønn · Oppdatert 14. sep. 2026 · NCT05125302Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.